vs
富兰克林柯维（FC）与PROCEPT BioRobotics Corp（PRCT）财务数据对比。点击上方公司名可切换其他公司
PROCEPT BioRobotics Corp的季度营收约是富兰克林柯维的1.3倍（$83.1M vs $64.0M），富兰克林柯维净利率更高（-5.1% vs -38.1%，领先32.9%），PROCEPT BioRobotics Corp同比增速更快（20.2% vs -7.3%），过去两年PROCEPT BioRobotics Corp的营收复合增速更高（24.8% vs 2.2%）
富兰克林柯维总部位于美国犹他州盐湖城，是一家专业培训指导企业，面向各类组织与个人提供领导力提升、个人效能成长与业务执行领域的培训及评估服务。公司由富兰克林奎斯特与柯维领导力中心于1997年合并成立，最为人熟知的产品包括富兰克林柯维规划系统等。
PROCEPT BioRobotics是一家专注于研发和商业化泌尿外科手术机器人解决方案的医疗科技企业，其旗舰AquaBeam系统可为良性前列腺增生患者提供图像引导微创治疗，服务覆盖北美、欧洲等地区的医疗机构与患者。
FC vs PRCT — 直观对比
营收规模更大
PRCT
是对方的1.3倍
$64.0M
营收增速更快
PRCT
高出27.5%
-7.3%
净利率更高
FC
高出32.9%
-38.1%
两年增速更快
PRCT
近两年复合增速
2.2%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $64.0M | $83.1M |
| 净利润 | $-3.3M | $-31.6M |
| 毛利率 | 75.5% | 64.9% |
| 营业利润率 | -5.7% | -4.1% |
| 净利率 | -5.1% | -38.1% |
| 营收同比 | -7.3% | 20.2% |
| 净利润同比 | -378.5% | -27.9% |
| 每股收益（稀释后） | $-0.27 | $-0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FCPRCT
| Q1 26 | — | $83.1M | ||
| Q4 25 | $64.0M | $76.4M | ||
| Q3 25 | $71.2M | $83.3M | ||
| Q2 25 | $67.1M | $79.2M | ||
| Q1 25 | $59.6M | $69.2M | ||
| Q4 24 | $69.1M | $68.2M | ||
| Q3 24 | $84.1M | $58.4M | ||
| Q2 24 | $73.4M | $53.4M |
净利润FCPRCT
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $-3.3M | $-29.8M | ||
| Q3 25 | $4.4M | $-21.4M | ||
| Q2 25 | $-1.4M | $-19.6M | ||
| Q1 25 | $-1.1M | $-24.7M | ||
| Q4 24 | $1.2M | $-18.9M | ||
| Q3 24 | $12.0M | $-21.0M | ||
| Q2 24 | $5.7M | $-25.6M |
毛利率FCPRCT
| Q1 26 | — | 64.9% | ||
| Q4 25 | 75.5% | 60.6% | ||
| Q3 25 | 75.5% | 64.8% | ||
| Q2 25 | 76.5% | 65.4% | ||
| Q1 25 | 76.7% | 63.9% | ||
| Q4 24 | 76.3% | 64.0% | ||
| Q3 24 | 78.1% | 63.2% | ||
| Q2 24 | 76.6% | 59.0% |
营业利润率FCPRCT
| Q1 26 | — | -4.1% | ||
| Q4 25 | -5.7% | -40.6% | ||
| Q3 25 | 11.1% | -27.8% | ||
| Q2 25 | -3.3% | -28.0% | ||
| Q1 25 | -2.4% | -39.7% | ||
| Q4 24 | 2.1% | -28.9% | ||
| Q3 24 | 21.3% | -38.4% | ||
| Q2 24 | 11.4% | -50.3% |
净利率FCPRCT
| Q1 26 | — | -38.1% | ||
| Q4 25 | -5.1% | -39.1% | ||
| Q3 25 | 6.1% | -25.7% | ||
| Q2 25 | -2.1% | -24.7% | ||
| Q1 25 | -1.8% | -35.8% | ||
| Q4 24 | 1.7% | -27.6% | ||
| Q3 24 | 14.2% | -35.9% | ||
| Q2 24 | 7.8% | -48.0% |
每股收益（稀释后）FCPRCT
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $-0.27 | $-0.54 | ||
| Q3 25 | $0.34 | $-0.38 | ||
| Q2 25 | $-0.11 | $-0.35 | ||
| Q1 25 | $-0.08 | $-0.45 | ||
| Q4 24 | $0.09 | $-0.34 | ||
| Q3 24 | $0.89 | $-0.40 | ||
| Q2 24 | $0.43 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $17.5M | $245.6M |
| 总债务越低越好 | — | $51.7M |
| 股东权益账面价值 | $54.0M | $347.7M |
| 总资产 | $221.3M | $487.1M |
| 负债/权益比越低杠杆越低 | — | 0.15× |
8季度趋势，按日历期对齐
现金及短期投资FCPRCT
| Q1 26 | — | $245.6M | ||
| Q4 25 | $17.5M | $286.5M | ||
| Q3 25 | $31.7M | $294.3M | ||
| Q2 25 | $33.7M | $302.7M | ||
| Q1 25 | $40.4M | $316.2M | ||
| Q4 24 | $53.3M | $333.7M | ||
| Q3 24 | $48.7M | $196.8M | ||
| Q2 24 | $36.6M | $214.1M |
总债务FCPRCT
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
股东权益FCPRCT
| Q1 26 | — | $347.7M | ||
| Q4 25 | $54.0M | $365.9M | ||
| Q3 25 | $66.9M | $380.3M | ||
| Q2 25 | $65.6M | $385.8M | ||
| Q1 25 | $72.5M | $389.2M | ||
| Q4 24 | $80.6M | $402.2M | ||
| Q3 24 | $83.1M | $241.2M | ||
| Q2 24 | $72.2M | $251.8M |
总资产FCPRCT
| Q1 26 | — | $487.1M | ||
| Q4 25 | $221.3M | $508.1M | ||
| Q3 25 | $242.9M | $511.5M | ||
| Q2 25 | $218.3M | $513.1M | ||
| Q1 25 | $221.3M | $519.4M | ||
| Q4 24 | $239.9M | $534.0M | ||
| Q3 24 | $261.5M | $374.1M | ||
| Q2 24 | $221.0M | $374.4M |
负债/权益比FCPRCT
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $98.0K | — |
| 自由现金流经营现金流 - 资本支出 | $-1.6M | — |
| 自由现金流率自由现金流/营收 | -2.5% | — |
| 资本支出强度资本支出/营收 | 2.7% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $5.9M | — |
8季度趋势，按日历期对齐
经营现金流FCPRCT
| Q1 26 | — | — | ||
| Q4 25 | $98.0K | $-10.3M | ||
| Q3 25 | $9.9M | $-6.6M | ||
| Q2 25 | $6.3M | $-15.0M | ||
| Q1 25 | $-1.4M | $-17.0M | ||
| Q4 24 | $14.1M | $-32.4M | ||
| Q3 24 | $21.9M | $-18.8M | ||
| Q2 24 | $8.2M | $-15.7M |
自由现金流FCPRCT
| Q1 26 | — | — | ||
| Q4 25 | $-1.6M | $-12.2M | ||
| Q3 25 | $5.7M | $-9.5M | ||
| Q2 25 | $4.5M | $-17.8M | ||
| Q1 25 | $-2.6M | $-18.8M | ||
| Q4 24 | $13.1M | $-33.6M | ||
| Q3 24 | $20.8M | $-19.0M | ||
| Q2 24 | $7.3M | $-16.8M |
自由现金流率FCPRCT
| Q1 26 | — | — | ||
| Q4 25 | -2.5% | -15.9% | ||
| Q3 25 | 8.0% | -11.4% | ||
| Q2 25 | 6.7% | -22.5% | ||
| Q1 25 | -4.4% | -27.2% | ||
| Q4 24 | 19.0% | -49.2% | ||
| Q3 24 | 24.7% | -32.6% | ||
| Q2 24 | 9.9% | -31.4% |
资本支出强度FCPRCT
| Q1 26 | — | — | ||
| Q4 25 | 2.7% | 2.4% | ||
| Q3 25 | 5.9% | 3.4% | ||
| Q2 25 | 2.7% | 3.5% | ||
| Q1 25 | 2.1% | 2.7% | ||
| Q4 24 | 1.4% | 1.7% | ||
| Q3 24 | 1.3% | 0.4% | ||
| Q2 24 | 1.2% | 2.0% |
现金转化率FCPRCT
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.27× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 11.98× | — | ||
| Q3 24 | 1.83× | — | ||
| Q2 24 | 1.43× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FC
暂无分部数据
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
